Starting next week, Monday, October 19th, developers of human or veterinary medicines are instructed to use the European Medicines Agency’s (EMA) new IRIS Regulatory & Scientific Information Management Platform to request scientific advice.

The new system aims to provide a single space for applicants to submit requests, communicate, share information, and deliver documents concerning each scientific advice procedure.

Found here: the objective is that at any stage of a medicine’s development, the developer can ask for guidance and direction from EMA. This includes scientific advice for both human and veterinary, and also protocol assistance and qualification procedures for human medicines.

With a much easier route to obtaining information, the EMA is making solid strides in streamlining processes and reducing the overall time needed for applicants to prepare and submit applications for scientific procedures. It additionally ensures better data quality through integration with other EMA systems allowing users to check the status of their applications across multiple devices and receive automatic updates when their status changes.

Stay updated on all the industry news by following us on LinkedIn!

Additional News

  • 18 July 2023

    Challenges of a large-scale study of breast cancer

    Our bioanalytical experts and a high-profile client team up for the development of a new therapy for breast cancer.

  • 29 June 2023

    EU funding for Quinta-Analytica laboratory in Brno (CZ) was succesfully completed.

    After two years, the project to finance new equipment for the Quinta-Analytica laboratory in Brno was successfully completed. The investment from European Regional Development Fund was used in this project.

  • 22 June 2023

    Quinta Analytica Partners with EvidentIQ to Enhance Efficiency of Phase 1 Studies

    EvidentIQ partners with Quinta-Analytica to enhance Phase 1 study efficiency